Marker Therapeutics
MRKR
MRKR
70 hedge funds and large institutions have $134M invested in Marker Therapeutics in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 15 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
25% more repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 12
0.34% more ownership
Funds ownership: 3.36% → 3.71% (+0.34%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
70
Holding in Top 10
1
Calls
$1.02M
Puts
$567K
Top Buyers
| 1 | +$12.9M | |
| 2 | +$3.77M | |
| 3 | +$1.57M | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.09M |
| 5 |
OCM
Osterweis Capital Management
San Francisco,
California
|
+$945K |
Top Sellers
| 1 | -$7.13M | |
| 2 | -$1.4M | |
| 3 | -$1.17M | |
| 4 |
Barclays
London,
United Kingdom
|
-$811K |
| 5 |
Goldman Sachs
New York
|
-$474K |